Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorKok, T.en
dc.contributor.authorBarancek, K.en
dc.contributor.authorBurrell, C.en
dc.identifier.citationJournal of Clinical Microbiology, 1990; 28(6):1458-1459en
dc.description.abstractA premarket trial of the Becton Dickinson Directigen respiratory syncytial virus membrane-based enzyme immunoassay compared the test with virus isolation for the detection of respiratory syncytial virus in 583 nasopharyngeal aspirates. After modification, the Directigen test showed a sensitivity of 83% and a specificity of 90%. It offers the potential for an efficient bedside test--without the need for any equipment--for the diagnosis of respiratory syncytial virus infection and requires only a 0.25-ml sample volume. However, for optimum reliability, freezing-thawing of samples and access to a confirmatory test were shown to be necessary.en
dc.description.statementofresponsibilityTuckweng Kok, Kristina Barancek, and Christopher J. Burrellen
dc.publisherAmerican Society for Microbiologyen
dc.rightsCopyright © 1990, American Society for Microbiologyen
dc.subjectNasopharynx; Cells, Cultured; Animalsen
dc.titleEvaluation of the Becton Dickinson Directigen test for respiratory syncytial virus in nasopharyngeal aspiratesen
dc.typeJournal articleen
pubs.library.collectionMedicine publicationsen
Appears in Collections:Medicine publications

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.